BioInsights - Vol 6 Issue 8

CELL & GENE THERAPY INSIGHTS

September 2020 Issue

Vol 6 Issue 8

SPOTLIGHT

Scaling up/out: cost-effective and robust transitioning through the clinic to commercial manufacture

Jan Thirkettle
Guest Editor:
Jan Thirkettle, Chief Development Officer at Freeline Therapeutics Limited

Foreword


Expert Insight


Innovator Insight


Commentary


Interview


Podcast


Expert Roundtable Video


Expert Roundtable


FastFacts


Supply Chain FOCUS

Biopreservation and cold chain management

Interview


Expert Insight


Innovator Insight


Journal articles

Expert Insight

Perspective

Interview

Webinars